ARTICLE | Company News
Pevion Biotech, NovaDigm, Italian National Health Institute deal
June 30, 2014 7:00 AM UTC
NovaDigm received exclusive, worldwide rights to Candida albicans secretory aspartyl proteinase 2 ( Sap2), a Candida vaccine antigen, from Pevion and Italian National Health Institute. NovaDigm plans...